New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
The Pharma Data
JANUARY 15, 2021
Food and Drug Administration to approve Tyvaso for ILD patients. Doctors are allowed to prescribe FDA-approved medications for unapproved uses when they believe it’s medically appropriate.). The trial, funded by Tyvaso maker United Therapeutics, involved 326 patients. © 2021 HealthDay.
52 
Let's personalize your content